| Application no. and date | 02782404.4 (espacenet) (Federated) (European Patent Register), 20021204 | | Patent/reg. no. and date | DK/EP 1453521, 20130904 | | Publication date | 20040908 | | Priority no. and date | US 335807 P, 20011205 | | EP pub. no. and date |
EP 1453521 20040908 | | Effective date | | | Applicant/owner | Teva Women's Health, Inc., 400 Chestnut Ridge Road
Woodcliff Lake, NJ 07677, US | | Applicant ref. no. | P52607DK01 | | Inventor | BELL, Robert, G.,
c/o Barr Research, One Bala Plaza,Suite 324
Bala Cynwyd, PA 19004, US,
BEN-MAIMON, Carole,
c/o Barr Research, One Bala Plaza,Suite 324
Bala Cynwyd, PA 19004, US,
ISKOLD, Beata,
c/o Barr Laboratories, Inc., 2 Quaker Road,Box 2900
Pomona, NY 10970, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/138 (2006.01) , A61K 31/56 (2006.01) , A61K 31/565 (2006.01) , A61K 31/567 (2006.01) , A61K 31/57 (2006.01) , A61K 45/06 (2006.01) , A61P 15/18 (2006.01) , A61P 25/24 (2006.01) | | Title | ORALE PRÆVENTIONSMIDLER TIL AT FORHINDRE GRAVIDITET OG MINDSKE PRÆMENSTRUEL SYMPTOMATOLOGI | | Int. application no. | US2002038602 | | Int. publication no. | WO2003049744 | | Related patent (certificate) | CA 2016 00016 | | Status | Ophævet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
